Paper9733870
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
Belyakov IM and 8 others. J Virol, 1998. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. Papers, record 9733870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9733870
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| HIV Envelope Protein gp160 | Major topic |
| Immunity, Mucosal | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Vaccines, Synthetic | Major topic |
| Vaccinia virus | Major topic |
| Animals | |
| Cell Line | |
| Cross Reactions | |
| Defective Viruses | |
| Female | |
| Immunologic Memory | |
| Interleukin-6 | |
| Mice | |
| Mice, Inbred BALB C | |
| Rectum | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2789433 | A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. | Science | 1989 | https://conductscience.org/library/papers/2789433 | PubMed |
| 2 | 2452443 | An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2452443 | PubMed |
| 3 | 2685955 | Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign. | Res Virol | 1989 | https://conductscience.org/library/papers/2685955 | PubMed |
| 4 | 1689366 | An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. | J Exp Med | 1990 | https://conductscience.org/library/papers/1689366 | PubMed |
| 5 | 2182912 | Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. | J Virol | 1990 | https://conductscience.org/library/papers/2182912 | PubMed |
| 6 | 2033387 | Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. | J Gen Virol | 1991 | https://conductscience.org/library/papers/2033387 | PubMed |
| 7 | 2047875 | Vaccinia virus: a tool for research and vaccine development. | Science | 1991 | https://conductscience.org/library/papers/2047875 | PubMed |
| 8 | 1371784 | Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. | J Immunol | 1992 | https://conductscience.org/library/papers/1371784 | PubMed |
| 9 | 1316930 | Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. | J Exp Med | 1992 | https://conductscience.org/library/papers/1316930 | PubMed |
| 10 | 1512047 | Cells and cytokines in mucosal immunity and inflammation. | Gastroenterol Clin North Am | 1992 | https://conductscience.org/library/papers/1512047 | PubMed |
| 11 | 1438287 | Nonreplicating vaccinia vector efficiently expresses recombinant genes. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1438287 | PubMed |
| 12 | 8421498 | Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. | Nature | 1993 | https://conductscience.org/library/papers/8421498 | PubMed |
| 13 | 8245770 | H-2Dd exploits a four residue peptide binding motif. | J Exp Med | 1993 | https://conductscience.org/library/papers/8245770 | PubMed |
| 14 | 7975844 | A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. | Vaccine | 1994 | https://conductscience.org/library/papers/7975844 | PubMed |
| 15 | 7530749 | Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. | J Immunol | 1995 | https://conductscience.org/library/papers/7530749 | PubMed |
| 16 | 8648709 | Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. | J Virol | 1996 | https://conductscience.org/library/papers/8648709 | PubMed |
| 17 | 8673922 | Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. | Nat Med | 1996 | https://conductscience.org/library/papers/8673922 | PubMed |
| 18 | 8674120 | A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. | Cell | 1996 | https://conductscience.org/library/papers/8674120 | PubMed |
| 19 | 8709274 | Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. | J Virol | 1996 | https://conductscience.org/library/papers/8709274 | PubMed |
| 20 | 8760802 | Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760802 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36679860 | Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36679860 | PubMed |
| 33072113 | A Systemic Prime-Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection. | Front Immunol | 2020 | https://conductscience.org/library/papers/33072113 | PubMed |
| 29374075 | Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity. | J Immunol | 2018 | https://conductscience.org/library/papers/29374075 | PubMed |
| 29257056 | Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins. | Vaccines (Basel) | 2017 | https://conductscience.org/library/papers/29257056 | PubMed |
| 28056224 | Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery. | J Gen Virol | 2017 | https://conductscience.org/library/papers/28056224 | PubMed |
| 26523292 | New prospects for a preventive HIV-1 vaccine. | J Virus Erad | 2015 | https://conductscience.org/library/papers/26523292 | PubMed |
| 23666811 | Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1. | Immunol Res | 2014 | https://conductscience.org/library/papers/23666811 | PubMed |
| 22038530 | GUCY2C-targeted cancer immunotherapy: past, present and future. | Immunol Res | 2011 | https://conductscience.org/library/papers/22038530 | PubMed |
| 21928282 | Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells. | Eur J Immunol | 2011 | https://conductscience.org/library/papers/21928282 | PubMed |
| 20624114 | Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. | Expert Opin Biol Ther | 2010 | https://conductscience.org/library/papers/20624114 | PubMed |
| 20122733 | Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells. | Leuk Res | 2010 | https://conductscience.org/library/papers/20122733 | PubMed |
| 20045097 | One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge. | Vaccine | 2010 | https://conductscience.org/library/papers/20045097 | PubMed |
| 19571797 | Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. | Mucosal Immunol | 2009 | https://conductscience.org/library/papers/19571797 | PubMed |
| 19159014 | A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. | PLoS One | 2009 | https://conductscience.org/library/papers/19159014 | PubMed |
| 18796634 | The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation. | Blood | 2008 | https://conductscience.org/library/papers/18796634 | PubMed |
| 18793787 | Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. | Virology | 2008 | https://conductscience.org/library/papers/18793787 | PubMed |
| 18412969 | Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. | BMC Immunol | 2008 | https://conductscience.org/library/papers/18412969 | PubMed |
| 18048074 | Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA. | Virology | 2008 | https://conductscience.org/library/papers/18048074 | PubMed |
| 17706843 | HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice. | Vaccine | 2007 | https://conductscience.org/library/papers/17706843 | PubMed |
| 17170437 | Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization. | J Gen Virol | 2007 | https://conductscience.org/library/papers/17170437 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ENPEP | 2028 | PubTator's text mining | https://conductscience.org/library/genes/2028 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9733870
GET https://conductscience.org/api/papers/v1/9733870/references?page=2